Ushbu ish iqtibos qilgan ishlar

305 ta ish

Ish: Tumor microenvironment and nanotherapeutics: intruding the tumor fort

Hallmarks of Cancer: The Next Generation
Douglas Hanahan, Robert A. Weinberg
Sharh maqola201118 iqtibos
ABI
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy, Jeffrey W. Pollard
Sharh maqola20145 iqtibos
ABI
Carbon nanotubes in drug delivery: Focus on anticancer therapies
Ammu V. V. V. Ravi Kiran, Garikapati Kusuma Kumari, Praveen Thaggikuppe Krishnamurthy
Maqola20205 iqtibos
ABI
Dissecting the Dual Nature of Hyaluronan in the Tumor Microenvironment
Muhan Liu, Cornelia Tölg, Eva A. Turley
Sharh maqola20194 iqtibos
ABI
Reactive oxygen species in cancer
Geou‐Yarh Liou, Peter Störz
Sharh maqola20104 iqtibos
ABI
Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance
Shizhu Chen, Keni Yang, Ruslan G. Tuguntaev +4
Sharh maqola20153 iqtibos
ABI
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Rakesh K. Jain
Sharh maqola20013 iqtibos
ABI
Combining immunotherapy and targeted therapies in cancer treatment
Matthew W. Vanneman, Glenn Dranoff
Sharh maqola20123 iqtibos
ABI
THE METABOLISM OF TUMORS IN THE BODY
Otto Warbürg, Franz Wind, Erwin Negelein
Maqola19273 iqtibos
ABI
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Gökhan S. Hotamışlıgil, Narinder S. Shargill, Bruce M. Spiegelman
Maqola19933 iqtibos
ABI
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar, Sima Patel, Evgenii N. Tcyganov +1
Sharh maqola20163 iqtibos
ABI
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Yoshihiro Ohue, Hiroyoshi Nishikawa
Sharh maqola20193 iqtibos
ABI
Nano-Enhanced Drug Delivery and Therapeutic Ultrasound for Cancer Treatment and Beyond
Priyanka Tharkar, Ramya Varanasi, Wu Shun Felix Wong +2
Sharh maqola20193 iqtibos
ABI
Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application
Jing Xie, Ye Bi, Huan Zhang +4
Sharh maqola20203 iqtibos
ABI
Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles
Rong Liu, Dong Li, Bin He +5
Maqola20112 iqtibos
ABI
Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs
Lin Zhu, Federico Perche, Tao Wang +1
Maqola20142 iqtibos
ABI
Surface Charge Switchable Nanoparticles Based on Zwitterionic Polymer for Enhanced Drug Delivery to Tumor
Youyong Yuan, Chengqiong Mao, Xiao‐Jiao Du +3
Maqola20122 iqtibos
ABI
Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer
Wei Guan, Junhui Hu, Lu Yang +6
Maqola20182 iqtibos
ABI
Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy
Longfa Kou, Rui Sun, Shuyi Xiao +7
Maqola20192 iqtibos
ABI
Glutathione Metabolism and Its Implications for Health
Guoyao Wu, Joanne R. Lupton, Nancy D. Turner +2
Sharh maqola20042 iqtibos
ABI
Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma
Kouji Tanaka, Akira Itô, Takeshi Kobayashi +5
Maqola20052 iqtibos
ABI
Iron Oxide Nanoparticles for Magnetically-Guided and Magnetically-Responsive Drug Delivery
Joan Estelrich, Elvira Escribano, Josep Queralt +1
Sharh maqola20152 iqtibos
ABI
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock, Vicki Plaks, Zena Werb
Sharh maqola20102 iqtibos
ABI
Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS
Hiroshi Maeda, Tomohiro Sawa, Toshimitsu Konno
Sharh maqola20012 iqtibos
ABI
High interstitial fluid pressure — an obstacle in cancer therapy
Carl‐Henrik Heldin, Kristofer Rubin, Kristian Pietras +1
Sharh maqola20042 iqtibos
ABI